Support for higher ciprofloxacin AUC24/MIC targets in treating Enterobacteriaceae bloodstream infection

Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia

(2010) Aryun Kim et al.   CLINICAL THERAPEUTICS

Pharmacodynamics of Levofloxacin in a Murine Pneumonia Model of Pseudomonas aeruginosa Infection: Determination of Epithelial Lining Fluid Targets

(2009) A. Louie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics–pharmacodynamics of quinolones against Streptococcus pneumoniae in patients with community-acquired pneumonia

(2008) Sujata M. Bhavnani et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Ciprofloxacin use in critically ill patients: pharmacokinetic and pharmacodynamic approaches

(2008) Jean-Marie Conil et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

(2008) Peggy S. McKinnon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic–pharmacodynamic models with Monte Carlo simulation

(2008) Christopher R. Frei et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Ciprofloxacin pharmacokinetics in critically ill patients: A prospective cohort study

(2008) Arthur R.H. van Zanten et al.   JOURNAL OF CRITICAL CARE